The role of prostaglandin receptors in regulating cerebral blood flow in the perinatal period

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 5, 1996, Pages 517-524

  Chemtob, Sylvain ^a,b   Li, Ding You ^a   Abran, Daniel ^a   Hardy, Pierre ^a   Peri, Krishna ^a   Varma, Daya R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cerebral blood flow; Cerebral vasculature; Intraventricular haemorrhage; Newborn; Prostaglandin E2; Prostaglandin F(2 ); Prostaglandin receptors; Prostaglandins

Indexed keywords

IBUPROFEN; PROSTAGLANDIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR;

AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN VENTRICLE HEMORRHAGE; DRUG EFFECT; HUMAN; NEWBORN; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; VASOCONSTRICTION;

EID: 0030066578     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14077.x     Document Type: Review

References (107)

1. Campbell WB. Lipid-derived autacoids: eicosanoids and platelet activating factor. In: Gileman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th ed., New York: Pergamon Press, 1990:600-17
2. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259:315-24
3. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-7
4. Kennedy I, Coleman RA, Humphey PPA, Levy GP, Lumley P. Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 1982;24:667-89
5. Eglen RM, Whiting RL. Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitro. Br J Pharmacol 1989;98:1335-43
6. Coleman RA, Grix SP, Head SA, Loutit JB, Mallett A, Shelderick RLG. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994;47:151-68
7. 2 sensitive (EP) receptors. Br J Pharmacol 1987;91:407P
8. Leffler CW, Busija DW, Beasley DG, Fletcher AM. Maintainance of cerebral circulation during hemorrhagic hypotension in newborn pigs: role of prostanoids. Circ Res 1986;59:562-7
9. Leffler CW, Busija DW. Prostanoids and pial arteriolar diameter in hypotensive newborn pigs. Am J Physiol 1987;252:H687-91
10. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure: Cerebral blood flow autoregulation of the newborn. Circ Res 1990;67:674-82
11. Leffler CW, Busija DW. Arachidonate metabolism on the cerebral surface of newborn pigs. Prostaglandins 1985;30:811-7
12. Ment LR, Steward WB, Duncan CC, Pitt BR, Cole J. Beagle puppy model of perinatal cerebral infarction: regional cerebral prostaglandin changes during acute hypoxemia. J Neurosurg 1986;65:851-5
13. Ment LR, Steward WB, Duncan CC, Pitt BR, Cole J. Beagle puppy model of brain injury: regional cerebral blood flow and cerebral prostaglandins. J Neurosurg 1987;67:278-83
14. Abran D, Varma DR, Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol 1995;268:H628-32
15. Chemtob S, Hardy P, Abran D, Li DY, Peri K, Varma DR. Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol 1995;78:2039-46
16. Perlman JM, McMenamin JB, Volpe JJ. Fluctuating cerebral blood flow velocity in respiratory distress syndrome: relationship to the development of intraventricular hemorrhage. New Engl J Med 1983;309:209-13
17. Perlman JM, Goodman S, Kreusser KL, Volpe JJ. Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood flow velocity in preterm infants with respiratory distress syndrome. New Engl J Med 1985;313:1353-7
18. Silverman WA, Flynn JT. Overview: a 'developmental' retinopathy reconsidered. In: Silverman WA, Flynn JT, editors. Retinopathy of prematurity II. Contemporary issues in fetal and neonatal medecine. Boston: Blackwell, 1985:xi-xxiii
19. Lassen NA, Chistensen MS. Physiology of cerebral blood flow. Br J Anaesth 1976;48:719-34
20. 2, and pH? Microvasc Res 1976;10:298-311
21. Rapela CE, Green HD. Autoregulation of canine cerebral blood flow. Circ Res 1964;14 Suppl 1:205-11
22. Hernandez MJ, Brennan RW, Bowman GS. Autoregulation of cerebral blood flow in the newborn dog. Brain Res 1980;184:199-202
23. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21:777-84
24. Bada HS, Korones SB, Perry EH, Arheart KL, Ray JD, Pourcyrous M et al. Mean blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr 1990;117:607-14
25. Trommer BL, Groothuis DR, Pasternak JF. Quantitative analysis of cerebral vessels in the newborn puppy: the structure of germinal matrix vessels may predispose to hemorrhage. Pediatr Res 1987;22:23-8
26. Pickard JD. Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J Cerebral Blood Flow Metab 1981;1:361-84
27. White RP, Hagen AA. Cerebrovascular actions of prostaglandins. Pharmacol Ther 1982;18:313-31
28. Murphy S, Pearce B. Eicosanoids in the CNS: sources and effects. Prostaglandin Leukotrienes Essential Fatty Acids 1988;31:165-70
29. Leslie CA, Watkins WD. Eicosanoids in the central nervous system. J Neurosurg 1985;63:659-68
30. Jones SA, Adamson SL, Bishai I, Lees J, Engelberts D, Coceani F. Eicosanoids in third ventricular cerebrospinal fluid of fetal and newborn sheep. Am J Physiol 1993;264:R135-42
31. Peri KG, Hardy P, Li DY, Varma DR, Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem 1995;270:24615-20
32. Chemtob S, Aranda JV, Varma DR. Effects of prostaglandins on isolated internal carotid and basilar arteries of the newborn and adult pig. Pediatr Rev Commun 1989;4:101-9
33. Gaudet RJ, Levine L. Transient cerebral ischemia and brain prostaglandins. Biochem Biophys Res Commun 1979;86:893-901
34. Katusic ZS, Shephard JT, Vanhoutte PM. Endothelium-dependent contractions to stretch in canine basilar arteries. Am J Physiol 1987;252:H671-3
35. Hayashi S, Park MK, Kuehl TJ. Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries. J Pharmacol Exp Ther 1985;233:628-35
36. Chemtob S, Guest I, Potvin W, Varma DR. Ontogeny of responses of rabbit aorta to atrial natriuretic factor and isoproterenol. Dev Pharmacol Ther 1991;16:108-15
37. Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994;124:951-5
38. Chemtob S, Laudignon N, Beharry K, Rex J, Varma DR, Wolfe L et al. Effects of prostaglandins and indomethacin on cerebral blood and cerebral oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther 1990;14:1-14
39. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys J. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989;84:802-7
40. Ment LR, Steward WB, Duncan CC, Scott DT, Lambrecht R. Beagle puppy model of intraventricular hemorrhage. Effect of indomethacin on cerebral blood flow. J Neurosurg 1983;58: 857-62
41. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJ, Scott DT et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988;112:948-55
42. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988;82:533-42
43. Schoepp DD, Rutledge CO. Comparison of postnatal changes in alpha 1-adrenoceptor binding and adrenergic stimulation of phosphoinositide hydrolysis in rat cerebral cortex. Biochem Pharmacol 1985;34:2705-11
44. Liang BT, Hellmich MR, Neer EJ, Galper JB. Development of muscarinic cholinergic inhibition of adenylate cyclase in embronic chick heart. Its relationship to changes in inhibitory guanine nucleotide regulatory protein. J Biol Chem 1986;261:9011-21
45. Kitamura Y, Mochii M, Kodama R, Agata K, Watanabe K, Eguchi G et al. Ontogenesis of alpha 2-adrenoceptors coupling with GTP-binding proteins in the rat telencephalon. J Neurochem 1989;53:249-55
46. Suba EA, Roth BL. Prostaglandins activate phosphoinositide metabolism in rat aorta. Eur J Pharmacol 1987;136:325-32
47. Heaslip RJ, Sickels BD. Evidence that prostaglandins can contract the rat aorta via a novel protein kinase C-dependent mechanism. J Pharmacol Exp Ther 1989;250:44-51
48. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 1991;28:129-37
49. Robertson RP. Characterization and regulation of prostaglandin and leukotriene receptors: an overview. Prostaglandins 1986;31:395-411
50. 2 alpha in postmortem human brain. Brain Res 1985;342:110-16
51. 2 alpha binding sites in monkey brain. Brain Res 1989;478:143-8
52. 2 to rat brain membranes and synaptosomes. Brain Res 1982;236:227-33
53. 2A receptors in brain synaptosomes of newborn than of adult pigs. J Pharmacol Exp Ther 1993;267:1292-7
54. 2A receptor density in brain microvessels of pigs. Br J Pharmacol 1994;112:59-64
55. 2 receptors in the retinal vasculature of pigs. Prostaglandins 1996;50(5-6):253-68
56. 2 receptor subtypes in porcine ocular tissue. 2. Nonuveal tissues. J Ocular Pharmacol Ther 1995;11:437-45
57. Lawrence RA, Jones RL, Wilson NH. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on guinea-pig ileum. Br J Pharmacol 1992;105:271-8
58. Coleman RA, Smith W, Narumiya S. VIII. International Union of Pharmacology Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-29
59. Dong YJ, Jones RL, Wilson NH. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol 1986;87:97-107
60. Senior J, Marshall K, Sangha R, Baxter GS, Clayton JK. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br J Pharmacol 1991;102:747-53
61. 1 subtype of prostaglandin E receptor. J Biol Chem 1993;268:20175-8
62. 1 subtype. J Biol Chem 1993;268:26767-72
63. Abran D, Varma DR, Li DY, Chemtob S. Reduced response of the retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can J Physiol Pharmacol 1994;72:168-73
64. 2A receptors, their second messengers and vasoconstriction. J Pharmacol Exp Ther. In press
65. 2 subtype. Mol Pharmacol 1994;46:213-20
66. Chen MC, Amirian DA, Toomey M, Sanders MJ, Soll AH. Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase. Gastroenterology 1988;94:1121-29
67. 2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes. Eur J Biochem 1988; 172:293-7
68. 2 interrelationships. J Clin Invest 1984;74:63-74
69. 3 subtype. J Biol Chem 1992:267:6463-6
70. 3 subtype. Biochem Biophys Res Commun 1993;194:885-91
71. 2 receptor. J Biol Chem 1994;269:6163-9
72. 2. Biochem Biophys Res Commun 1994;198:999-1006
73. 3 determines G-protein specificity. Nature 1993;365:166-70
74. 2A receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs. J Pharmacol Exp Ther 1995;272:15-9
75. 2 alpha in bovine corpora lutea: relative affinities of products of arachidonic acid metabolism by cyclooxygenase. Biochem Biophys Res Commun 1978;85:125-30
76. Behrman HR, Luborsky JL, Aten RF, Polan ML, Tarlatzis BC, Haseltine FP et al. Luteolytic hormones are calcium-mediated, guanine nucleotide antagonists of gonadotrophin-sensitive adenylate cyclase. Adv Prostaglandin Thomboxane Leukotriene Res 1985;15:601-4
77. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metiers KM et al. Cloning and expression of a cDNA for the human prostanoid FP receptors. J Biol Chem 1995;269:2632-6
78. Sugimoto Y, Hasumoto K, Namba T, Irie A, Katsuyama M, Negishi M et al. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem 1994;269:1356-60
79. 2 alpha receptor. J Biol Chem 1994;269:3881-6
80. Baumbach GL, Heistad DD. Regional, segmental, and temporal heterogeneity of cerebral vascular autoregulation. Ann Biomed Eng 1985;13:303-10
81. 1 receptor-mediated human vascular smooth muscle relaxation. J Cardiovasc Pharmacol 1992;19:447-52
82. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest 1995;96:99-106
83. Robertson RP, Westcott KR, Storm DR, Rice MG. Downregulation in vivo of PGE receptors and adenylate cyclase stimulation. Am J Physiol 1980;239:E75-80
84. 2 receptor in rat renal medulla. Arch Biochem Biophys 1987;259:89-97
85. Rice MG, McRoe JR, Storm DR, Robertson RP. Upregulation of hepatic prostaglandin E receptors in vivo induced by prostaglandin synthesis inhibitors. Am J Physiol 1981; 241:E291-7
86. Garrity MJ, Andreasen TJ, Storm DR, Robertson RP. Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex. J Biol Chem 1983;258:8692-7
87. Jaschonek K, Faul C, Schmidt H, Renn W. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase. Eur J Pharmacol 1988;147:187-96
88. Benovic JL, Regan JW, Matsui H, Mayer F Jr, Cotecchia S, Leeb-Lundberg LM et al. Agonist-dependent phosphorylation of the alpha 2-adrenergic receptor by the beta-adrenergic receptor kinase. J Biol Chem 1987;262:17251-3
89. Dohlman HG, Bouvier M, Benovic JL, Caron MG, Lefkowitz RJ. The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis. J Biol Chem 1987;262:14282-8
90. Hausdorff WP, Bouvier M, O'Dowd B, Irons F, Caron GP, Lefkowitz RJ. Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem 1989;264:12657-65
91. Negishi M, Sugimoto Y, Ichikawa A. Prostanoid receptors and their biological actions. Prog Lipid Res 1993;32:417-34
92. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Ann Rev Neurosci 1992;15:87-114
93. Linder ME, Middleton P, Hepler JR, Taussig R, Gilman AG, Numby SM. Lipid modification of G proteins: alpha subunits are palmitoylated. Proc Natl Acad Sci USA 1993;90:3675-79
94. 2 receptor binding in the central nervous system. J Lipid Mediator 1993;6:445-51
95. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990;4:2881-9
96. Hadcock JR, Wang H, Malbon CC: Agonist-induced destabilization of beta-adrencrgic receptor mRNA. Alteration of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem 1989;264:19928-33
97. Collins S, Bouvier M, Bolanowski MA, Caron MG, Lefkowitz RJ. cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short-term agonist exposure. Proc Natl Acad Sci USA 1989;86:4853-7
98. Nishikawa M, Mak JC, Shirasaki H, Barnes PJ. Differential downregulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline. Eur J Pharmacol 1993;247:131-8
99. Mitchell MD, Lucas A, Etches PC, Brant JD, Turnbull AC. Plasma prostaglandin levels during early neonatal life following term and preterm delivery. Prostaglandins 1978;16:319-26
100. Hooper TL, Thomson DS, Jones MT, Cook L, Owen S, Wilkes S et al. Amelioration of lung ischemic injury with prostacyclin. Transplantation 1990;49:1031-5
101. 1. Am Rev Respir Dis 1993;148:882-9
102. 2 analogue (OP-41483) on energy metabolism in liver preservation and its relation to lipid peroxide reperfusion injury in rats. Cryobiology 1993;30:459-65
103. 2 receptor antagonist (ONO 3708) on ischemia-reperfusion injury in the dog pancreas. Transplantation 1994;57:187-93
104. 1 induces cFos and Myc proteins and protects rat hyppocampal cells against hypoxic injury. J Cereb Blood Flow Metab 1994;14:150-5
105. Tarnawski A, Brzozowski T, Sarfeh IJ, Krause WJ, Ulich TR, Gergely H et al. Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. J Clin Invest 1988;81:1081-9
106. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette J et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995;83:473-82
107. Dildy GA, ven den Berg PP, Katz M, Clark SL, Jongsma HW, Nijhuis JG et al. Intrapartum fetal pulse oximetry: fetal oxygen saturation trends during labor and relation to delivery outcome. Am J Obstet Gynecol 1994;17;:679-94